Copyright
©The Author(s) 2020.
World J Stem Cells. Jan 26, 2020; 12(1): 87-99
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Figure 2 Expression of hypoxia-inducible factor-2α and CD44 in MCF-7 and MDA-MB-231 cells (×200).
The expression of HIF-2α and CD44 in MDA-MB-231 cells was significantly higher than that in MCF-7 cells. HIF-2α: Hypoxia-inducible factor-2α; DAPI : 4',6-diamidino-2-phenylindole.
- Citation: Bai J, Chen WB, Zhang XY, Kang XN, Jin LJ, Zhang H, Wang ZY. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling. World J Stem Cells 2020; 12(1): 87-99
- URL: https://www.wjgnet.com/1948-0210/full/v12/i1/87.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i1.87